Immune Repertoire Sequencing Market Projected to Growth at a CAGR of ~6% throughout 2022 2031

(MENAFN- Comserve)

New York, United States, Mar 25, 2022, 05:46 /Comserve / -- The global immune repertoire sequencing market is estimated to occupy a substantial revenue by growing at a CAGR of ~6% during the forecast period, i.e., 2022 – 2031.

Research Nester published a report titled “Immune Repertoire Sequencing Market: Global Demand Analysis & Opportunity Outlook 2031” which delivers detailed overview of the global immune repertoire sequencing market in terms of market segmentation by product type, application, end user, and by region.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.

The global immune repertoire sequencing market is estimated to occupy a substantial revenue by growing at a CAGR of ~6% during the forecast period, i.e., 2022 – 2031, ascribing to the growing number of launches of novel medical products, and increase in government funding to improve the healthcare infrastructure, particularly in developing nations. Along with these, escalating occurrence of cancer around the world, and rising utilization of immune repertoire sequencing for biomarkers discovery and cancer immunotherapy are also expected to drive the growth of the market in the forthcoming years.

Download Sample of This Strategic Report @

The market is segmented by product type, application and end user. Based on application, the cancer immunotherapy segment is anticipated to witness significant growth during the forecast period in view of the surging usage of the technique to study the role of the immune system in the progression and development of cancer. Additionally, by end user, the pharmaceutical companies segment is projected to acquire the largest share over the forecast period attributing to the escalating investments by companies regarding the development of more effective products for treating infectious diseases.

Geographically, the global immune repertoire sequencing market is segmented into five major regions, namely North America, Europe, Latin America, Asia Pacific, and the Middle East & Africa. North America is evaluated to gather the largest share in the market during the forecast period attributing to the high healthcare expenditure, and strong presence of major market players in the region. Moreover, the market in Asia Pacific is assessed to witness noteworthy growth over the forecast period on the back of the rise in the number of international collaborations for immune repertoire sequencing in the region.

The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players' competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.

Request a Sample Copy of Concerned Market Report @

Growing Number of Novel Product Launches by Pharmaceutical Companies to Drive Market Growth

Over the last two decades, pharmaceutical companies and academic institutes are emphasizing on use of immune repertoire sequencing for a variety of applications, including biomarkers discovery, cancer immunotherapy, asthma and allergies and infectious diseases research. This can be credited to the ability of this technique in marking antigens specific information within lymphocytes, which in turn is anticipated to drive significant market growth in the near future.

However, dearth of skilled personnel in lower economic regions is expected to operate as key restraint to the growth of the global immune repertoire sequencing market over the forecast period.

This report also provides the existing competitive scenario of some of the key players of the global immune repertoire sequencing market which includes company profiling of Agilent Technologies, Inc, Illumina, Inc., Pacific Biosciences of California, Inc, QIAGEN N.V., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche AG, Takara Bio, Inc, Oxford Nanopore Technologies, Ltd, BGI Group, Atreca Inc, and others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global immune repertoire sequencing market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

Curious about this latest version of report? Obtain Report Details @

Research Nester is a one-stop service provider, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives to make wise decisions for their future investment and expansion by providing them qualitative market insights and strategies while avoiding future uncertainties. We believe in honesty and sheer hard work that we trust is reflected in our work ethics. Our vision is not just limited to gain the trust of our clients but also to be equally respected by our employees and being appreciated by the competitors.

MENAFN25032022004694010674ID1103913699